Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia

Ann Hematol. 2014 Sep;93(9):1611-2. doi: 10.1007/s00277-014-2010-7. Epub 2014 Jan 23.

Authors

Maria Ilaria Del Principe¹, Mariagiovanna Cefalo, Francesco Buccisano, Lucia Anemona, Chiara Sarlo, Luigi Di Caprio, Giovanna De Santis, Erica Giacobbi, Luca Maurillo, Massimiliano Postorino, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti

Affiliation

¹ Cattedra di Ematologia, Dipartimento Biomedicina e Prevenzione, Università Tor Vergata, Rome, Italy, [email protected].

PMID: 24452366
DOI: 10.1007/s00277-014-2010-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aging / pathology
Anemia, Hemolytic, Autoimmune / complications*
Anemia, Hemolytic, Autoimmune / drug therapy*
Anemia, Hemolytic, Autoimmune / pathology
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
B-Lymphocytes / pathology
Epstein-Barr Virus Infections / complications
Epstein-Barr Virus Infections / diagnosis
Epstein-Barr Virus Infections / drug therapy
Epstein-Barr Virus Infections / pathology
Humans
Lymphoproliferative Disorders / complications*
Lymphoproliferative Disorders / drug therapy*
Lymphoproliferative Disorders / virology
Male
Middle Aged
Red-Cell Aplasia, Pure / complications*
Red-Cell Aplasia, Pure / drug therapy*
Red-Cell Aplasia, Pure / pathology
Rituximab

Substances

Antibodies, Monoclonal, Murine-Derived
Rituximab